Dapsone Gel
Product Images NDC 68308-342

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 68308-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dapsone 01)

FDA Label Image

Principal Display Panel (90 g Bottle Carton)

Principal Display Panel (90 g Bottle Carton)
This is a description of Dapsone Gel, 7.5% distributed by Mayne Pharma. It is manufactured in India and for topical use only, not for oral, opthalmic or intravaginal use. The recommended dosage is to apply once daily and the package insert should be consulted for dosage information. The gel consists of Homopolymer type C, methyiparaben, sodium fluoride, and purified water. The storage temperature recommended is between 20°C to 25°C, and it should be kept out of reach. The expiration date is 0512021. The NDC code is 68308-342:90, and the product is available by prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.